Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 23, Pages 2927-2935
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-07-09
DOI
10.1200/jco.2012.48.5052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
- (2012) Tobias Rausch et al. CELL
- Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
- (2012) Regina I. Jakacki et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
- (2012) Trevor J. Pugh et al. NATURE
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- Dissecting the genomic complexity underlying medulloblastoma
- (2012) David T. W. Jones et al. NATURE
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- The clinical implications of medulloblastoma subgroups
- (2012) Paul A. Northcott et al. Nature Reviews Neurology
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
- (2011) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
- (2011) Paul A. Northcott et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients
- (2011) F. Magrangeas et al. BLOOD
- Rapid Diagnosis of Medulloblastoma Molecular Subgroups
- (2011) E. C. Schwalbe et al. CLINICAL CANCER RESEARCH
- Adult Medulloblastoma Comprises Three Major Molecular Variants
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- FSTL5Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas
- (2011) Janet C. Lindsey et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease
- (2011) Marco Gessi et al. JOURNAL OF NEURO-ONCOLOGY
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
- (2011) Anita Villani et al. LANCET ONCOLOGY
- TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
- (2010) Uri Tabori et al. JOURNAL OF CLINICAL ONCOLOGY
- Universal Poor Survival in Children With Medulloblastoma Harboring SomaticTP53Mutations
- (2010) Uri Tabori et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma
- (2010) Elke Pfaff et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
- (2010) David W. Ellison et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
- (2008) Marcel Kool et al. PLoS One
- Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome
- (2008) A. Shlien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started